Statin Drugs
 
A multi billion dollar industry

An article from Natural News

Statins are gateway drugs for Big Pharma: Take one and youll need four or five more prescriptions for the side effects

One out of every three American adults take statins, and if you think that sounds like good news for statin manufacturers, youre missing the bigger picture. All of Big Pharma benefits when people take statins. In fact, statins can really be thought of as gateway drugs. After all, they have so many side effects that you will likely end up taking several other medications after you start statins just to deal with them.

What can happen to you if you take these dangerous drugs? They suppress your bodys immune system, rendering it less able to fight off infections. They also inhibit production of coenzyme Q10, which helps to regulate your immune and nervous system and maintain a healthy heart and blood pressure. Theres also a higher risk of neurological diseases when you take statins, with many patients reporting forgetfulness, confusion and memory loss. But dont worry whatever happens to you, Big Pharma has a solution for that, too!

Statins also increase your risk of diabetes, so much so that the FDA has required that a warning label be placed on the package informing people of the link between statins, higher blood glucose levels and diabetes. The risk is especially heightened if you are an older woman. An Australian study found that elderly women who took high doses of statins had a 50 percent higher risk of developing diabetes. This could mean youll end up on diabetes medication for the rest of your life.

And for what benefit are you placing yourself at so much risk? According to research published in BMJ, taking statins over the course of two to five years adds just 3.2 days to a patients lifespan on average if the side effects dont kill them first. Yes, theyve been approved by the FDA, but how many times has the FDA had to pull drugs after initially approving them as their dangers became too obvious to ignore?

 

END PAGE